Inventor · disambiguated record
Claire Mégret
Also filed as: MEGRET CLAIRE · MÉGRET CLAIRE
37 granted patents·7 pending applications·701 citations·filing 2017–2025
98Inventor score
Files withFLAMEL IRELAND LTD44
Top patents by PatentIndex Score
44 records- 0199US11839597B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2021·Granted Dec 12, 2023·27 cites·30 claims
- 0299US11065224B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2019·Granted Jul 20, 2021·42 cites·38 claims
- 0399US10973795B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2019·Granted Apr 13, 2021·48 cites·24 claims
- 0499US10952986B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2019·Granted Mar 23, 2021·50 cites·31 claims
- 0598US11052061B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2019·Granted Jul 6, 2021·33 cites·24 claims
- 0698US11000498B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2019·Granted May 11, 2021·38 cites·20 claims
- 0797US12128021B1Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2024·Granted Oct 29, 2024·12 cites·26 claims
- 0897US12097175B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2023·Granted Sep 24, 2024·9 cites·30 claims
- 0997US11986451B1Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2021·Granted May 21, 2024·24 cites·26 claims
- 1097US11504347B1Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2021·Granted Nov 22, 2022·38 cites·25 claims
- 1197US10736866B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2019·Granted Aug 11, 2020·53 cites·52 claims
- 1297US10272062B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2017·Granted Apr 30, 2019·68 cites·89 claims
- 1396US12257223B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2024·Granted Mar 25, 2025·2 cites·14 claims
- 1496US12138239B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2023·Granted Nov 12, 2024·9 cites·30 claims
- 1596US12115145B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2023·Granted Oct 15, 2024·10 cites·29 claims
- 1696US12115144B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2023·Granted Oct 15, 2024·10 cites·15 claims
- 1796US12115143B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2023·Granted Oct 15, 2024·10 cites·26 claims
- 1896US12115142B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2023·Granted Oct 15, 2024·10 cites·30 claims
- 1996US11896572B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2023·Granted Feb 13, 2024·28 cites·1 claims
- 2096US11826335B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2023·Granted Nov 28, 2023·27 cites·10 claims
- 2196US11766418B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2022·Granted Sep 26, 2023·27 cites·11 claims
- 2296US11602512B1Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2021·Granted Mar 14, 2023·36 cites·11 claims
- 2396US11602513B1Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2021·Granted Mar 14, 2023·36 cites·27 claims
- 2496US11583510B1Methods of administering gamma hydroxybutyrate formulations after a high-fat mealFLAMEL IRELAND LTD·Filed 2022·Granted Feb 21, 2023·37 cites·14 claims
- 2595US12226388B2Modified release gamma- hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2024·Granted Feb 18, 2025·2 cites·29 claims
- 2695US11779557B1Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2022·Granted Oct 10, 2023·7 cites·6 claims
- 2794US12263150B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2024·Granted Apr 1, 2025·1 cites·19 claims
- 2894US12263151B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2024·Granted Apr 1, 2025·1 cites·15 claims
- 2994US12239625B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2024·Granted Mar 4, 2025·1 cites·15 claims
- 3094US12226389B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2024·Granted Feb 18, 2025·1 cites·14 claims
- 3194US12186298B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2024·Granted Jan 7, 2025·1 cites·26 claims
- 3294US12109186B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2023·Granted Oct 8, 2024·1 cites·11 claims
- 3393US12186296B1Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2021·Granted Jan 7, 2025·2 cites·63 claims
- 3489US12144793B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2023·Granted Nov 19, 2024·0 cites·23 claims
- 3589US12097176B2Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2023·Granted Sep 24, 2024·0 cites·6 claims
- 3689US2024366548A1Modified release gamma- hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2024·Application pending·0 cites
- 3784US2025099417A1Modified release gamma- hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2024·Application pending·0 cites
- 3880US2022016066A1Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2021·Application pending·0 cites
- 3980US2025205187A1Modified release gamma- hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2025·Application pending·0 cites
- 4079US2021267928A1Modified release gamma- hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2021·Application pending·0 cites
- 4178US2023210804A1Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2023·Application pending·0 cites
- 4274US12478604B1Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2022·Granted Nov 25, 2025·0 cites·15 claims
- 4372US12295926B1Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2022·Granted May 13, 2025·0 cites·7 claims
- 4443US2025152546A1Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Claire Mégret files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →